Cresco Labs (CRLBF) Equity Average (2021 - 2026)

Cresco Labs has reported Equity Average for 6 years, with the latest figure at $248.4 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 41.59% year-over-year to $248.4 million; the trailing twelve-month figure through Mar 2026 stood at $248.4 million (down 41.59% YoY), and the FY2025 full-year result was $363.7 million, down 19.44% from the prior year.
• Equity Average for Q1 2026 stood at $248.4 million, down from $296.3 million in the prior quarter.
• The five-year high for Equity Average was $777.5 million in Q3 2022, with the low at $248.4 million in Q1 2026.
• Historically, Equity Average has averaged $490.5 million across 5 years, with a median of $425.2 million in 2025.
• Annual changes were most pronounced in 2025 — Equity Average grew 0.28% — and 2026, when it tumbled 41.59%.
• Cresco Labs' Equity Average stood at $679.6 million in 2022, then plunged by 37.17% to $427.0 million in 2023, then declined by 1.61% to $420.1 million in 2024, then decreased by 29.46% to $296.3 million in 2025, then decreased by 16.19% to $248.4 million in 2026.
• The last three Equity Average figures came in at $248.4 million (Q1 2026), $296.3 million (Q4 2025), and $350.5 million (Q3 2025), per Business Quant data.